Use of a maggot motility index to evaluate survival of therapeutic larvae.
暂无分享,去创建一个
D. Armstrong | A. Boulton | Heather R. Kimbriel | B. P. Nixon | B. Short | J. R. Vazquez | M. J. Claxton | A. Rosales
[1] D. Armstrong,et al. Maggot debridement therapy: a primer. , 2002, Journal of the American Podiatric Medical Association.
[2] K. Mumcuoglu,et al. Maggot débridement therapy in outpatients. , 2001, Archives of physical medicine and rehabilitation.
[3] R. Shinkman. Worms and squirms. Maggots, leeches are making a comeback in modern medicine. , 2000, Modern healthcare.
[4] J. Stessman,et al. Maggot therapy for the treatment of diabetic foot ulcers. , 1998, Diabetes care.
[5] J. Graner. S.K. Livingston and the maggot therapy of wounds. , 1997, Military medicine.
[6] P. Prete,et al. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. , 1997, Life sciences.
[7] S. K. Livingston. Clinical results following the use of a surgical jelly containing the maggot active principle , 1938 .
[8] S. K. Livingston. THE THERAPEUTIC ACTIVE PRINCIPLE OF MAGGOTS , 1936 .